These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36593091)

  • 1. Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells.
    Meyer A; Sienes RE; Nijim W; Zanotti B; Umar S; Volin MV; Van Raemdonck K; Lewis M; Pitzalis C; Arami S; Al-Awqati M; Chang HJ; Jetanalin P; Schett G; Sweiss N; Shahrara S
    Ann Rheum Dis; 2023 Apr; 82(4):483-495. PubMed ID: 36593091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesis.
    Meyer A; Zack SR; Nijim W; Burgos A; Patel V; Zanotti B; Volin MV; Amin MA; Lewis MJ; Pitzalis C; Arami S; Karam JA; Sweiss NJ; Shahrara S
    Cell Mol Immunol; 2024 Jan; 21(1):33-46. PubMed ID: 38105293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony-Stimulating Factor Receptor.
    Van Raemdonck K; Umar S; Palasiewicz K; Volin MV; Elshabrawy HA; Romay B; Tetali C; Ahmed A; Amin MA; Zomorrodi RK; Sweiss N; Shahrara S
    Arthritis Rheumatol; 2021 Nov; 73(11):2003-2014. PubMed ID: 33982895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming of macrophages instigates CCL21-induced arthritis.
    Van Raemdonck K; Umar S; Palasiewicz K; Meyer A; Volin MV; Chang HJ; Al-Awqati M; Zomorrodi RK; Shahrara S
    Immunol Cell Biol; 2022 Feb; 100(2):127-135. PubMed ID: 34779007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models.
    Alzoubi O; Meyer A; Gonzalez TP; Burgos AC; Sweiss N; Zomorrodi RK; Shahrara S
    Clin Immunol; 2023 Jun; 251():109635. PubMed ID: 37150238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosion.
    Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Amin MA; Zomorrodi RK; Arami S; Gonzalez M; Rao V; Zanotti B; Fox DA; Sweiss N; Shahrara S
    Cell Mol Immunol; 2021 Sep; 18(9):2199-2210. PubMed ID: 32415262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRAK4 inhibitor mitigates joint inflammation by rebalancing metabolism malfunction in RA macrophages and fibroblasts.
    Umar S; Palasiewicz K; Volin MV; Zanotti B; Al-Awqati M; Sweiss N; Shahrara S
    Life Sci; 2021 Dec; 287():120114. PubMed ID: 34732329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types.
    Umar S; Palasiewicz K; Volin MV; Romay B; Rahat R; Tetali C; Arami S; Guma M; Ascoli C; Sweiss N; Zomorrodi RK; O'Neill LAJ; Shahrara S
    Cell Mol Life Sci; 2021 Dec; 78(23):7693-7707. PubMed ID: 34705053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch ligands are biomarkers of anti-TNF response in RA patients.
    Zack SR; Meyer A; Zanotti B; Volin MV; Deen S; Satoeya N; Sweiss N; Lewis MJ; Pitzalis C; Kitajewski JK; Shahrara S
    Angiogenesis; 2024 May; 27(2):273-283. PubMed ID: 37796367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis.
    Van Raemdonck K; Umar S; Palasiewicz K; Volkov S; Volin MV; Arami S; Chang HJ; Zanotti B; Sweiss N; Shahrara S
    Cell Mol Life Sci; 2020 Apr; 77(7):1387-1399. PubMed ID: 31342120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis.
    Pickens SR; Chamberlain ND; Volin MV; Pope RM; Talarico NE; Mandelin AM; Shahrara S
    Arthritis Rheum; 2011 Oct; 63(10):2884-93. PubMed ID: 21647866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.
    Palasiewicz K; Umar S; Romay B; Zomorrodi RK; Shahrara S
    Eur J Immunol; 2021 Sep; 51(9):2330-2340. PubMed ID: 34107055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of IL-7 and IL-7R in RA and autoimmunity.
    Meyer A; Parmar PJ; Shahrara S
    Autoimmun Rev; 2022 Jul; 21(7):103120. PubMed ID: 35595051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
    Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
    Front Immunol; 2020; 11():613975. PubMed ID: 33679701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
    Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
    Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR7 endogenous ligands remodel glycolytic macrophages and trigger skin-to-joint crosstalk in psoriatic arthritis.
    Van Raemdonck K; Umar S; Palasiewicz K; Romay B; Volkov S; Arami S; Sweiss N; Shahrara S
    Eur J Immunol; 2021 Mar; 51(3):714-720. PubMed ID: 33079387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamics of interleukin (IL)-18 in serum, synovial fluid and synovial membrane in the patients with rheumatoid arthritis].
    Munakata T; Uzuki M; Shimamura T; Sawai T
    Ryumachi; 2001 Jun; 41(3):625-34. PubMed ID: 11505512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
    Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
    Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
    Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.